{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:20:19Z","timestamp":1780975219827,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0055"],"award-info":[{"award-number":["P1-0055"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.05.013","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T21:52:27Z","timestamp":1588888347000},"page":"671-677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Diabetes and metabolic syndrome as risk factors for COVID-19"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-1162","authenticated-orcid":false,"given":"Marko","family":"Marhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-8520","authenticated-orcid":false,"given":"Vladimir","family":"Grubelnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u0161a","family":"Magdi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-6373","authenticated-orcid":false,"given":"Rene","family":"Markovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.05.013_bib1","doi-asserted-by":"crossref","first-page":"108132","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: the conundrum","volume":"162","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.05.013_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2020.05.013_bib3","article-title":"COVID-19 pandemic, corona viruses, and diabetes mellitus","volume":"2020","author":"Muniyappa","year":"2020","journal-title":"Am J Physiol Metab"},{"key":"10.1016\/j.dsx.2020.05.013_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2020.05.013_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2020.05.013_bib6","first-page":"841","article-title":"Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)","volume":"9","author":"Brake","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.dsx.2020.05.013_bib7","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.dsx.2020.05.013_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2020.03.002","article-title":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2020.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22818","article-title":"Obesity and its implications for COVID-19 mortality","author":"Dietz","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.dsx.2020.05.013_bib11","series-title":"Global report on diabetes","author":"Roglic","year":"2016"},{"key":"10.1016\/j.dsx.2020.05.013_bib12","unstructured":"IDF Atlas 9th edition and other resources n.d. https:\/\/www.diabetesatlas.org\/en\/resources\/."},{"key":"10.1016\/j.dsx.2020.05.013_bib13","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.dsx.2020.05.013_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.dsx.2020.05.013_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.dsx.2020.05.013_bib16","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1093\/bioinformatics\/btz385","article-title":"Entrezpy: a Python library to dynamically interact with the NCBI Entrez databases","volume":"35","author":"Buchmann","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.dsx.2020.05.013_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1109\/JPROC.2015.2483592","article-title":"A\u00a0review of relational machine learning for knowledge graphs","volume":"104","author":"Nickel","year":"2016","journal-title":"Proc IEEE"},{"key":"10.1016\/j.dsx.2020.05.013_bib18","doi-asserted-by":"crossref","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2020.05.013_bib19","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.dsx.2020.05.013_bib20","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A\u00a0human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2020.05.013_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2020.05.013_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.dsx.2020.05.013_bib23","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.dsx.2020.05.013_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2008.09.020","article-title":"The sweeter side of ACE2: physiological evidence for a role in diabetes","volume":"302","author":"Bindom","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.013_bib25","series-title":"Report based on available data on March 26th","article-title":"Characteristics of COVID-19 patients dying in Italy","author":"Palmieri","year":"2020"},{"key":"10.1016\/j.dsx.2020.05.013_bib26","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.2337\/db10-1205","article-title":"ACE2 and diabetes: ACE of ACEs?","volume":"59","author":"Batlle","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.05.013_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20130344","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications","volume":"126","author":"Patel","year":"2014","journal-title":"Clin Sci"},{"key":"10.1016\/j.dsx.2020.05.013_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor Axis: evidence from basic and clinical research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.dsx.2020.05.013_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2020.05.013_bib30","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.05.013_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.biopha.2018.10.191","article-title":"The renin-angiotensin system as a target to solve the riddle of endocrine pancreas homeostasis","volume":"109","author":"Graus-Nunes","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.dsx.2020.05.013_bib32","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.05.013_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FJC.0000000000000307","article-title":"ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy","volume":"66","author":"Cole-Jeffrey","year":"2015","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.dsx.2020.05.013_bib34","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.dsx.2020.05.013_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","author":"Diaz","year":"2020","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.dsx.2020.05.013_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.32604\/cmc.2020.010691","article-title":"Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity","volume":"62","author":"Jiang","year":"2020","journal-title":"Comput Mater Continua (CMC)"},{"key":"10.1016\/j.dsx.2020.05.013_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14455","article-title":"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China","author":"Zhang","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.dsx.2020.05.013_bib38","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.2337\/diabetes.53.11.2855","article-title":"Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of scotland coronary prevention study","volume":"53","author":"Sattar","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.05.013_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1758-5996-2-65","article-title":"Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound","volume":"2","author":"Esteghamati","year":"2010","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2020.05.013_bib40","first-page":"8","article-title":"The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus","volume":"12","author":"Mahran","year":"2017","journal-title":"J\u00a0Taibah Univ Med Sci"},{"key":"10.1016\/j.dsx.2020.05.013_bib41","article-title":"Elevated liver enzymes in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease","volume":"10","author":"Mandal","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.dsx.2020.05.013_bib42","first-page":"e5166","article-title":"Prevalence and association of elevated liver transaminases in type 2 diabetes mellitus patients in jeddah, Saudi arabia","volume":"11","author":"Alzahrani","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.dsx.2020.05.013_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fendo.2017.00236","article-title":"High liver enzyme concentrations are associated with higher glycemia, but not with glycemic variability, in individuals without diabetes mellitus","volume":"8","author":"Noordam","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.dsx.2020.05.013_bib44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","article-title":"Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes","volume":"19","author":"Sanyal","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2020.05.013_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2337\/diaclin.23.3.115","article-title":"Elevated liver function tests in type 2 diabetes","volume":"23","author":"Harris","year":"2005","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.dsx.2020.05.013_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.dsx.2020.05.013_bib47","first-page":"3404","article-title":"Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in changsha","volume":"24","author":"Zheng","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.dsx.2020.05.013_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032678","article-title":"Charting the NF-\u03baB pathway interactome map","volume":"7","author":"Tieri","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2020.05.013_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/1471-2105-15-333","article-title":"Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies","volume":"15","author":"Moni","year":"2014","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.dsx.2020.05.013_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc3497","article-title":"How ageing processes influence cancer","volume":"13","author":"de Magalh\u00e3es","year":"2013","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.dsx.2020.05.013_bib51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mad.2014.01.004","article-title":"The role of low-grade inflammation and metabolic flexibility in aging and nutritional modulation thereof: a systems biology approach","volume":"136\u2013137","author":"Cal\u00e7ada","year":"2014","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.dsx.2020.05.013_bib52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.dsx.2020.05.013_bib53","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1073\/pnas.0701361104","article-title":"The human disease network","volume":"104","author":"Goh","year":"2007","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.dsx.2020.05.013_bib54","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1073\/pnas.0701722105","article-title":"Network properties of genes harboring inherited disease mutations","volume":"105","author":"Feldman","year":"2008","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.dsx.2020.05.013_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2014.01.009","article-title":"Metformin modulates PI3K and GLUT4 expression and Akt\/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin","volume":"175","author":"Ferreira","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.dsx.2020.05.013_bib56","doi-asserted-by":"crossref","first-page":"107092","DOI":"10.1016\/j.diabres.2017.10.004","article-title":"Akt activation: a potential strategy to ameliorate insulin resistance","volume":"156","author":"Zhang","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2020.05.013_bib57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:14:24Z","timestamp":1761729264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120301326"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.05.013","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and metabolic syndrome as risk factors for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}